Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial
Division of Cardiology (111C), VA Medical Center, 1 Veterans Drive, Minneapolis, MN 55417, USA
Received 18 July 2007; revised 13 November 2007; accepted 13 December 2007.
* Corresponding author. Tel: +1 612 467 3664, Fax: +1 612 727 5668, Email: mcfal00l{at}umn.edu
See page 283 for the editorial comment on this article (doi:10.1093/eurheartj/ehm521)
Aims: The predictors and outcomes of patients with a peri-operative elevation in cardiac troponin I above the 99th percentile of normal following an elective vascular operation have not been studied in a homogeneous cohort with documented coronary artery disease.
Methods and results: The Coronary Artery Revascularization Prophylaxis (CARP) trial was a randomized trial that tested the benefit of coronary artery revascularization prior to vascular surgery. Among 377 randomized patients, core lab samples for peak cardiac troponin I concentrations were monitored following the vascular operation and the blinded results were correlated with outcomes. A peri-operative myocardial infarction (MI), defined by an increase in cardiac troponin I greater than the 99th percentile reference (
0.1 µg/L), occurred in 100 patients (26.5%) and the incidence was not dissimilar in patients with and without pre-operative coronary revascularization (24.2 vs. 28.6%; P = 0.32). By logistic regression analysis, predictors of MI (odds risk; 95%CI; P-value) were age >70 (1.84; 1.14–2.98; P = 0.01), abdominal aortic surgery (1.82; 1.09–3.03; P = 0.02), diabetes (1.86; 1.11–3.11; P = 0.02), angina (1.67; 1.03–2.64; P = 0.04), and baseline STT abnormalities (1.62; 1.00–2.6; P = 0.05). At 2.5 years post-surgery, the probability of survival in patients with and without the MI was 0.73 and 0.84, respectively (P = 0.03, log-rank test). Using a Cox proportional hazards regression analysis, a peri-operative MI in diabetic patients was a strong predictor of long-term mortality (hazards ratio: 2.43; 95% CI: 1.31–4.48; P < 0.01).
Conclusion: Among patients with coronary artery disease who undergo vascular surgery, a peri-operative elevation in cardiac troponin levels is common and in combination with diabetes, is a strong predictor of long-term mortality. These data support the utility of cardiac troponins as a means of stratifying high-risk patients following vascular operations.
Key Words: vascular surgery • myocardial infarction • coronary artery revascularization • outcomes • cardiac risks • troponins
Deceased.
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Preoperative cardiac risk assessment in vascular surgery patients: seeing beyond the perioperative period
- Olaf Schouten, Jeroen J. Bax, and Don Poldermans
EHJ 2008 29: 283-284.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  G. Landesberg, W. S. Beattie, M. Mosseri, A. S. Jaffe, and J. S. Alpert Perioperative Myocardial Infarction Circulation, June 9, 2009; 119(22): 2936 - 2944. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Garcia, T. E. Moritz, S. Goldman, F. Littooy, G. Pierpont, G. C. Larsen, D. J. Reda, H. B. Ward, and E. O. McFalls Perioperative Complications After Vascular Surgery Are Predicted by the Revised Cardiac Risk Index But Are Not Reduced in High-Risk Subsets With Preoperative Revascularization Circ Cardiovasc Qual Outcomes, March 1, 2009; 2(2): 73 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Pierpont and E. O. McFalls Interpreting troponin elevations: do we need multiple diagnoses? Eur. Heart J., January 2, 2009; 30(2): 135 - 138. [Full Text] [PDF]
|
|
|
|
 |
|
 S. Garcia and E. O. McFalls Preoperative Coronary Revascularization in High-Risk Patients Undergoing Vascular Surgery Anesth. Analg., October 1, 2008; 107(4): 1442 - 1443. [Full Text] [PDF]
|
|
|
|
|
|
O. Schouten, J. J. Bax, and D. Poldermans Preoperative cardiac risk assessment in vascular surgery patients: seeing beyond the perioperative period Eur. Heart J., February 1, 2008; 29(3): 283 - 284. [Full Text] [PDF]
|
|